Atsushi Mizokami

47PUBLICATIONS
68CO-AUTHORS
Molecular targetsMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|May 02, 2026
Fibroblast-mediated KRAS activation in double-negative prostate cancer.

|Apr 07, 2026
Urethral Closure Mechanism Caused by Prostate Rotation During Abdominal Pressure in Men: A Dynamic Magnetic Resonance Imaging Study.

Hiroshi Kano, Yoshifumi Kadono, Ryunosuke Nakagawa

|Mar 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study.

Shuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake

|Feb 27, 2026
High-Dose-Rate Brachytherapy Combined with External Beam Radiotherapy for Newly Defined Very High-Risk and Regional Prostate Cancer: A 17-Year Single-Institution Experience.

Tomoyuki Makino, Takayuki Sakurai, Shigeyuki Takamatsu

|Jan 12, 2026
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study.

Atsushi Mizokami, Rikiya Matsumoto, Hideaki Miyake

|Dec 30, 2025
Dynamic Changes in Albumin and Systemic Immune-Inflammation Index as Prognostic Markers in Patients Treated with Cabozantinib After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

Rikushi Fujimura, Hiroshi Yaegashi, Ryunosuke Nakagawa

Pageof 8

Frequent Collaborators

30 joint publications

Kouji Izumi

21 joint publications

Hiroaki Iwamoto

15 joint publications

Tomoyuki Makino

14 joint publications

Kazuyoshi Shigehara